COMMITTED TO MAKING A DIFFERENCE
Novavax, Inc. is a global biotechnology company committed to helping address serious infectious diseases globally through the discovery, development and delivery of innovative vaccines to patients around the world.
Our mission
We never rest in our quest to protect the health of people everywhere.
Novavax is here to make a difference. We're a biotech company focused solely on developing life-saving vaccines to fight infectious diseases.
Our commitment is backed by solid science tested by decades of research, vaccines developed from trusted technology and a global network that will help to ensure that our vaccines reach everyone who needs them.
Novavax is on a mission to protect the health of people everywhere and follow the highest standards of corporate governance. Learn more about our Environmental, Social and Governance (ESG) initiatives.
Novavax AB
Novavax AB is located in Uppsala, Sweden. This facility is responsible for research, development and production of our saponin-based adjuvants. Our Matrix-MTM is used in multiple vaccine candidates to enhance the immune response and stimulate high levels of neutralising antibodies.
Novavax CZ
Novavax CZ, located in Bohumil in the Czech Republic, was established in 2020. The facility is a state-of-the-art vaccine and biologics manufacturing campus dedicated to producing vaccines that help protect global health.
Novavax EU
From 2022, Novavax started to develop commercial hubs throughout Europe, with the regional main office in Zurich, Switzerland. Additional offices are now also established in Brussels, Belgium and Barcelona, Spain.
+44 020 3514 1838
09:00 - 17:00
Monday - Friday
More information is available on our global website, novavax.com.
Our location:
Novavax UK Limited
100 Longwater Avenue
Reading
RG2 6GP
United Kingdom
Email: [email protected]
Phone: +41 44 553 05 71
To contact a member of the investor relations team, click on the "Contact us" button below.